ID

44559

Beschrijving

A Safety and Efficacy Study of a Single or Double Dose of HEPLISAV™ Hepatitis B Vaccine in Adults With End-Stage Renal Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00498212

Link

https://clinicaltrials.gov/show/NCT00498212

Trefwoorden

Versies (2)
  1. 09-04-18 09-04-18 -
  2. 27-09-21 27-09-21 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

27 september 2021

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Hepatitis B NCT00498212

Engels

Eligibility Hepatitis B NCT00498212

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
willing and able to give written informed consent
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
have a glomerular filtration rate (gfr) ≤ 45 ml/min
Beschrijving

Glomerular Filtration Rate

Datatype

boolean

Alias
UMLS CUI [1]
C0017654
have an expectation of going on hemodialysis or are already on hemodialysis
Beschrijving

Hemodialysis Expected | Hemodialysis

Datatype

boolean

Alias
UMLS CUI [1,1]
C0019004
UMLS CUI [1,2]
C1517001
UMLS CUI [2]
C0019004
is serum negative for hepatitis b virus (hbv) antibodies, hepatitis c virus (hcv), and human immunodeficiency virus (hiv)
Beschrijving

Hepatitis B Antibodies Seronegative | Hepatitis C virus Seronegative | HIV Seronegative

Datatype

boolean

Alias
UMLS CUI [1,1]
C0019164
UMLS CUI [1,2]
C0521144
UMLS CUI [2,1]
C0220847
UMLS CUI [2,2]
C0521144
UMLS CUI [3,1]
C0019682
UMLS CUI [3,2]
C0521144
have repeated resting blood pressure measurements ≤ 165/105 mmhg
Beschrijving

Blood pressure measurement At rest Repeated

Datatype

boolean

Alias
UMLS CUI [1,1]
C0005824
UMLS CUI [1,2]
C0443144
UMLS CUI [1,3]
C0205341
women of childbearing potential must be consistently using a highly effective method of birth control
Beschrijving

Childbearing Potential Contraceptive methods

Datatype

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
women who are pregnant, breastfeeding or planning a pregnancy
Beschrijving

Pregnancy | Breast Feeding | Pregnancy, Planned

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
any previous hbv infection
Beschrijving

Hepatitis B Previous

Datatype

boolean

Alias
UMLS CUI [1,1]
C0019163
UMLS CUI [1,2]
C0205156
previous vaccination (1 or more doses) with any hbv vaccine
Beschrijving

Hepatitis B vaccination Dose Quantity

Datatype

boolean

Alias
UMLS CUI [1,1]
C0474232
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C1265611
any previous autoimmune diseases
Beschrijving

Autoimmune Diseases

Datatype

boolean

Alias
UMLS CUI [1]
C0004364
have a diagnosis of chronic renal failure due to autoimmune disease
Beschrijving

Chronic Kidney Failure Due to Autoimmune Diseases

Datatype

boolean

Alias
UMLS CUI [1,1]
C0022661
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0004364
are at high risk for recent exposure to hbv, hcv or hiv
Beschrijving

High risk Exposure to Hepatitis B Virus | High risk Exposure to Hepatitis C virus | High risk Exposure to HIV

Datatype

boolean

Alias
UMLS CUI [1,1]
C0332167
UMLS CUI [1,2]
C0332157
UMLS CUI [1,3]
C0019169
UMLS CUI [2,1]
C0332167
UMLS CUI [2,2]
C0332157
UMLS CUI [2,3]
C0220847
UMLS CUI [3,1]
C0332167
UMLS CUI [3,2]
C0332157
UMLS CUI [3,3]
C0019682
received any antibodies within 3 months prior to study entry
Beschrijving

Antibodies (medication)

Datatype

boolean

Alias
UMLS CUI [1]
C3495458
ever received an injection with dna plasmids or oligonucleotides
Beschrijving

Plasmids Injection | Oligonucleotides Injection

Datatype

boolean

Alias
UMLS CUI [1,1]
C0032136
UMLS CUI [1,2]
C1828121
UMLS CUI [2,1]
C0028953
UMLS CUI [2,2]
C1828121
received any vaccines within 4 weeks prior to study entry
Beschrijving

Vaccines

Datatype

boolean

Alias
UMLS CUI [1]
C0042210
received any other investigational medicinal agent within 4 weeks prior to study entry
Beschrijving

Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1]
C0013230
Terug naar het begin van de pagina

Similar models

Eligibility Hepatitis B NCT00498212

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
willing and able to give written informed consent
boolean
C0021430 (UMLS CUI [1])
Glomerular Filtration Rate
Item
have a glomerular filtration rate (gfr) ≤ 45 ml/min
boolean
C0017654 (UMLS CUI [1])
Hemodialysis Expected | Hemodialysis
Item
have an expectation of going on hemodialysis or are already on hemodialysis
boolean
C0019004 (UMLS CUI [1,1])
C1517001 (UMLS CUI [1,2])
C0019004 (UMLS CUI [2])
Hepatitis B Antibodies Seronegative | Hepatitis C virus Seronegative | HIV Seronegative
Item
is serum negative for hepatitis b virus (hbv) antibodies, hepatitis c virus (hcv), and human immunodeficiency virus (hiv)
boolean
C0019164 (UMLS CUI [1,1])
C0521144 (UMLS CUI [1,2])
C0220847 (UMLS CUI [2,1])
C0521144 (UMLS CUI [2,2])
C0019682 (UMLS CUI [3,1])
C0521144 (UMLS CUI [3,2])
Blood pressure measurement At rest Repeated
Item
have repeated resting blood pressure measurements ≤ 165/105 mmhg
boolean
C0005824 (UMLS CUI [1,1])
C0443144 (UMLS CUI [1,2])
C0205341 (UMLS CUI [1,3])
Childbearing Potential Contraceptive methods
Item
women of childbearing potential must be consistently using a highly effective method of birth control
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding | Pregnancy, Planned
Item
women who are pregnant, breastfeeding or planning a pregnancy
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Hepatitis B Previous
Item
any previous hbv infection
boolean
C0019163 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Hepatitis B vaccination Dose Quantity
Item
previous vaccination (1 or more doses) with any hbv vaccine
boolean
C0474232 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Autoimmune Diseases
Item
any previous autoimmune diseases
boolean
C0004364 (UMLS CUI [1])
Chronic Kidney Failure Due to Autoimmune Diseases
Item
have a diagnosis of chronic renal failure due to autoimmune disease
boolean
C0022661 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0004364 (UMLS CUI [1,3])
High risk Exposure to Hepatitis B Virus | High risk Exposure to Hepatitis C virus | High risk Exposure to HIV
Item
are at high risk for recent exposure to hbv, hcv or hiv
boolean
C0332167 (UMLS CUI [1,1])
C0332157 (UMLS CUI [1,2])
C0019169 (UMLS CUI [1,3])
C0332167 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
C0220847 (UMLS CUI [2,3])
C0332167 (UMLS CUI [3,1])
C0332157 (UMLS CUI [3,2])
C0019682 (UMLS CUI [3,3])
Antibodies (medication)
Item
received any antibodies within 3 months prior to study entry
boolean
C3495458 (UMLS CUI [1])
Plasmids Injection | Oligonucleotides Injection
Item
ever received an injection with dna plasmids or oligonucleotides
boolean
C0032136 (UMLS CUI [1,1])
C1828121 (UMLS CUI [1,2])
C0028953 (UMLS CUI [2,1])
C1828121 (UMLS CUI [2,2])
Vaccines
Item
received any vaccines within 4 weeks prior to study entry
boolean
C0042210 (UMLS CUI [1])
Investigational New Drugs
Item
received any other investigational medicinal agent within 4 weeks prior to study entry
boolean
C0013230 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial